Skip to main content
OpenTrials

Clinical trial condition

Female Urogenital Diseases and Pregnancy Complications

Explore clinical trials studying Female Urogenital Diseases and Pregnancy Complications. Study availability and eligibility vary by location and protocol.

27,094 public trials 4,558 recruiting studies
Refine in advanced search Browse all conditions

Female Urogenital Diseases and Pregnancy Complications trial results

Recruiting

Study of Trastuzumab Deruxtecan Versus Standard of Care Chemotherapy for HER2-Expressing (IHC 3+/2+) Endometrial Cancer

NCT07022483

Conditions
Endometrial Cancer, Endometrial Neoplasms, Female Urogenital Diseases, +10 more
Locations
  • Broward Health Medical Center Fort Lauderdale, Florida, United States
  • Miami Cancer Institute Miami, Florida, United States
  • Mount Sinai Medical Center Miami Beach, Florida, United States
  • Parkview Research Center Fort Wayne, Indiana, United States
View all 75 locations
View Trial Details
Recruiting

Inherited Reproductive Disorders

NCT01500447

Conditions
Amenorrhea, Congenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, +20 more
Locations
  • National Institutes of Health Clinical Center Bethesda, Maryland, United States
  • NIEHS Clinical Research Unit (CRU) Research Triangle Park, North Carolina, United States
View Trial Details
Recruiting

Phase 1 Study to Evaluate the Safety and Tolerability of Intravenously Administered PYC-003

NCT06714006

Conditions
Abnormalities, Multiple, Autosomal Dominant Polycystic Kidney Disease (ADPKD), Ciliopathies, +12 more
Locations
  • South Coast Renal, Brockway House, Level 1, Suite 8, 82-86 Queen Street, Southport, Gold Coast, Australia
  • Concord Repatriation General Hospital Concord, New South Wales, Australia
  • Liverpool Hospital, Clinic G-Reception 133, Level 1, Clinical Building, Burnside Drive Liverpool, New South Wales, Australia
  • Scientia Clinical Research Randwick, New South Wales, Australia
View Trial Details
Recruiting

A Phase II Randomized, Open Label Non-inferiority Study of NiraParib Maintenance After 3 vs. 6 Cycles of Platinum-based Chemotherapy in completeLy debUlked Advanced HRDpositive High-grade Ovarian Cancer patientS in First Line Therapy

NCT05460000

Conditions
Adenocarcinoma, Adenocarcinoma, Clear Cell, Adnexal Diseases, +23 more
Locations
  • Universitätsklinik Innsbruck Innsbruck, Austria
  • Cliniques Universitaires St. Luc Brussels, Belgium
  • UZ Gent Ghent, Belgium
  • Jessa ziekenhuis Hasselt, Belgium
View all 50 locations
View Trial Details

Related conditions